Journal Rank: CiteScore 2.7 - Q3 (Oncology)
Submission to first decision: 55 days

Journal of Cancer Metastasis and Treatment

Exclusive Interview of Professor Eric A Singer

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Pathogenesis of osteosarcoma and intervention with traditional chinese medicine

Open Access Review DOI: 10.20517/2394-4722.2025.31 19 Aug 2025
Views: Downloads:
Download PDF

A ferroptosis-based gene signature for relapse prediction in prostate adenocarcinoma

Open Access Original Article DOI: 10.20517/2394-4722.2025.73 12 Aug 2025
Views: Downloads:
Download PDF

Bioelectromagnetic fields in prostate cancer: molecular mechanisms and therapeutic implications

Open Access Perspective DOI: 10.20517/2394-4722.2025.72 10 Aug 2025
Views: Downloads:
Download PDF

Perioperative therapies for metastatic renal cell carcinoma

Open Access Perspective DOI: 10.20517/2394-4722.2025.43 3 Aug 2025
Views: Downloads:
Download PDF

Combining multiple approaches and omics technologies to detect circulating tumor cells (CTCs): a real clinical application in patients with early-stage non-small-cell lung cancer (NSCLC)?

Open Access Commentary DOI: 10.20517/2394-4722.2024.115 30 Jul 2025
Views: Downloads:
Download PDF

Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness

Open Access Review DOI: 10.20517/2394-4722.2023.34 29 Jun 2023
Views: Downloads:
Download PDF

Application of radiomics and artificial intelligence in lung cancer immunotherapy: a guide and hurdles from clinical trials

Open Access Review DOI: 10.20517/2394-4722.2023.10 6 Aug 2023
Views: Downloads:
Download PDF

Current diagnosis and management of cardiac melanoma: a case series and review

Open Access Case Report DOI: 10.20517/2394-4722.2022.113 6 Jul 2023
Views: Downloads:
Download PDF

Submission Deadline: 31 Dec 2026

Published articles: 0

Submission Deadline: 15 Mar 2026

Published articles: 0

Coming soon.

The IRGS model is a robust predictor of prognosis and immunotherapy response in GC, underscoring its potential clinical utility. Welcome to read the full study for more insights.
Unlocking the clinical potential of CTCs in early NSCLC demands continued innovation and validation.
50% APC discount for submissions from July 22 to December 31, 2025.
On June 9, 2025, the editorial team had the great honor of interviewing a pioneer in ovarian cancer research - Prof. Robert C. Bast fromThe University of Texas MD Anderson Cancer Center.
On March 20, 2025, the Journal of Cancer Metastasis and Treatment (JCMT) has been officially included in the Chinese Academy of Sciences (CAS) Journal Ranking system.

Exclusive Interview of Professor Eric A Singer

NaN

Submission Deadline: 31 Dec 2026

Published articles: 0

Submission Deadline: 15 Mar 2026

Published articles: 0

Coming soon.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/